Gerard Sanderink PhD is the Global Head of Biomarkers and Clinical Bioanalyses, Translational Medicine and Early Development, Sanofi R&D. The department develops and implements lab assays for clinical development in all Sanofi therapeutic areas, including the analysis of Biomarkers, Pharmacokinetics/drug metabolism and immunogenicity in four main labs in the US, France and Germany. The technologies employed are LBA, MS, Flow cytometry, Immunohistochemistry and genetics/genomics. He is based in Cambridge, MA